Clinical Trial to Evaluate Safety and Efficacy of Cell Therapy in Patients With Cicatricial Conjuntivitis.

Categoría Estudio primario
Registro de estudiosclinicaltrials.gov
Año 2022

Este artículo no está incluido en ninguna revisión sistemática

Cargando información sobre las referencias
A phase IIa, open label, non controlled clinical trial to assess the feasibility and safety of allogeneic adipose-derived mesenchymal stem cells (ASC) in the treatment of cicatricial conjunctivitis associated with Lyell\'s syndrome, Stevens-Johnson\'s syndrome and mucous membrane pemphigoid with ocular involvement
Epistemonikos ID: 634bcb26f2e019f64729a673190c490f68568fe1
First added on: May 13, 2024